Inscription Capital’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Inscription Capital's IDXX Position: Q2 2026 in Review
Inscription Capital increased its Idexx Laboratories (IDXX) stake by 56% in Q2 2026, buying an estimated $390K and bringing the position to 1,936 shares worth $1.02M. The position accounts for 0.09% of the portfolio, ranked #216.
Inscription Capital first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Inscription Capital held 1,936 shares of Idexx Laboratories worth $1.02M as of Q2 2026.
- Inscription Capital bought 695 Idexx Laboratories shares in Q2 2026, an estimated $390K.
- Idexx Laboratories made up 0.09% of Inscription Capital's portfolio in Q2 2026, its #216 holding.
- Inscription Capital first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.